Search - tctmd.com

Displaying 741 - 760 of 3077

Sort: Relevancy | Date

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

Presentation

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

Presenter: Dean J. Kereiakes

October 22, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Conference News TCT 2015

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Yael L. Maxwell

October 16, 2015

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory!

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Doris A. Taylor

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Presenter: Eric R. Bates, Spencer B. King III, Sanjay Kaul

October 13, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Industry News

Assessing Fractional Flow Reserve Using Computed Tomography Shown To Reduce Costs in Patients With Chest Pain

October 13, 2015

News Daily News

Test de troponina I de alta sensibilidad podría eliminar el IM en gran número de pacientes

Todd Neale

October 13, 2015

News Daily News

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

L.A. McKeown

October 13, 2015

Advertisement

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory!

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

Discussion Highlights Merits, Limitations of Small Trials

Assessing Fractional Flow Reserve Using Computed Tomography Shown To Reduce Costs in Patients With Chest Pain

Test de troponina I de alta sensibilidad podría eliminar el IM en gran número de pacientes

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content